Search

Your search keyword '"Abyholm T"' showing total 22 results
Start Over Author "Abyholm T" Journal human reproduction
22 results on '"Abyholm T"'

3. POSTER VIEWING SESSION - FEMALE (IN) FERTILITY

Author

Engman, M., primary, Bystrom, B., additional, Varghese, S., additional, Lalitkumar, P. G. L., additional, Gemzell-Danielsson, K., additional, Romeu, C., additional, Urries, A., additional, Lierta, M., additional, Sanchez Rubio, J., additional, Sanz, B., additional, Perez, I., additional, Casis, L., additional, Salerno, A., additional, Nazzaro, A., additional, Di Iorio, L., additional, Bonassisa, P., additional, Van Os, L., additional, Vink-Ranti, C. Q. J., additional, de Haan-Cramer, J. H., additional, Rijnders, P. M., additional, Jansen, C. A. M., additional, Marino, S., additional, Granato, C., additional, Pastore, E., additional, Brandes, M., additional, Hamilton, C. J. C. M., additional, de Bruin, J. P., additional, Bots, R. S. G. M., additional, Nelen, W. L. D. M., additional, Kremer, J. A. M., additional, Szkodziak, P., additional, Wozniak, S., additional, Czuczwar, P., additional, Paszkowski, T., additional, Agirregoitia, N., additional, Peralta, L., additional, Mendoza, R., additional, Exposito, A., additional, Matorras, R., additional, Agirregoitia, E., additional, Chuderland, D., additional, Ben-Ami, I., additional, Kaplan-Kraicer, R., additional, Grossman, H., additional, Satchi- Fainaro, R., additional, Eldar-Boock, A., additional, Ron-El, R., additional, Shalgi, R., additional, Custers, I. M., additional, Scholten, I., additional, Moolenaar, L. M., additional, Flierman, P. A., additional, Dessel, T. J. H. M., additional, Gerards, M. H., additional, Cox, T., additional, Janssen, C. A. H., additional, van der Veen, F., additional, Mol, B. W. J., additional, Wathlet, S., additional, Adriaenssens, T., additional, Verheyen, G., additional, Coucke, W., additional, Smitz, J., additional, Feliciani, E., additional, Ferraretti, A. P., additional, Paesano, C., additional, Pellizzaro, E., additional, Magli, M. C., additional, Gianaroli, L., additional, Hernandez, J., additional, Rodriguez-Fuentes, A., additional, Garcia-Guzman, R., additional, Palumbo, A., additional, Radunovic, N., additional, Tosic, T., additional, Djukic, S., additional, Lockwood, J. C., additional, Van Landuyt, L., additional, Karayalcin, R., additional, Ozcan, S. A. R. P., additional, Ozyer, S., additional, Gurlek, B., additional, Kale, I., additional, Moraloglu, O., additional, Batioglu, S., additional, Chaudhury, K., additional, Narendra Babu, K., additional, Mamata Joshi, V., additional, Srivastava, S., additional, Chakravarty, B. N., additional, Viardot-Foucault, V., additional, Prasath, E. B., additional, Tai, B. C., additional, Chan, J. K. Y., additional, Loh, S. F., additional, Cordeiro, I., additional, Leal, F., additional, Soares, A. P., additional, Nunes, J., additional, Sousa, S., additional, Aguiar, A., additional, Carvalho, M., additional, Calhaz-Jorge, C., additional, Karkanaki, A., additional, Piouk, A., additional, Katsikis, I., additional, Mousatat, T., additional, Koiou, E., additional, Daskalopoulos, G. N., additional, Panidis, D., additional, Tolikas, A., additional, Tsakos, E., additional, Gerou, S., additional, Prapas, Y., additional, Loufopoulos, A., additional, Abanto, E., additional, Barrenetxea, G., additional, Agirregoikoa, J., additional, Anarte, C., additional, De Pablo, J. L., additional, Burgos, J., additional, Komarovsky, D., additional, Friedler, S., additional, Gidoni, Y., additional, Ben-ami, I., additional, Strassburger, D., additional, Bern, O., additional, Kasterstein E, E., additional, Komsky, A., additional, Maslansky, B., additional, Raziel, A., additional, Fuentes, A., additional, Argandona, F., additional, Gabler, F., additional, Galleguillos, A., additional, Torres, A., additional, Palomino, W. A., additional, Gonzalez-Fernandez, R., additional, Pena, O., additional, Avila, J., additional, Talebi Chahvar, S., additional, Biondini, V., additional, Battistoni, S., additional, Giannubilo, S., additional, Tranquilli, A. L., additional, Stensen, M. H., additional, Tanbo, T., additional, Storeng, R., additional, Abyholm, T., additional, Fedorcsak, P., additional, Johnson, S. R., additional, Foster, L., additional, Ellis, J., additional, Choi, J. R., additional, Joo, J. K., additional, Son, J. B., additional, Lee, K. S., additional, Helmgaard, L., additional, Klein, B. M., additional, Arce, J. C., additional, Sanhueza, P., additional, Donoso, P., additional, Salinas, R., additional, Enriquez, R., additional, Saez, V., additional, Carrasco, I., additional, Rios, M., additional, Gonzalez, P., additional, Macklon, N., additional, Guo, M., additional, Richardson, M., additional, Wilson, P., additional, Chian, R. C., additional, Eapen, A., additional, Hrehorcak, M., additional, Campbell, S., additional, Nargund, G., additional, Oron, G., additional, Fisch, B., additional, Ao, A., additional, Freidman, O., additional, Zhang, X. Y., additional, Ben-Haroush, A., additional, Abir, R., additional, Hantisteanu, S., additional, Ellenbogen, A., additional, Hallak, M., additional, Michaeli, M., additional, Fainaru, O., additional, Maman, E., additional, Yong, G., additional, Kedem, A., additional, Yeruahlmi, G., additional, Konopnicki, S., additional, Cohen, B., additional, Dor, J., additional, Hourvitz, A., additional, Moshin, V., additional, Croitor, M., additional, Hotineanu, A., additional, Ciorap, Z., additional, Rasohin, E., additional, Aleyasin, A., additional, Agha Hosseini, M., additional, Mahdavi, A., additional, Safdarian, L., additional, Fallahi, P., additional, Mohajeri, M. R., additional, Abbasi, M., additional, Esfahani, F., additional, Elnashar, A., additional, Badawy, A., additional, Totongy, M., additional, Mohamed, H., additional, Mustafa, F., additional, Seidman, D. S., additional, Tadir, Y., additional, Goldchmit, C., additional, Gilboa, Y., additional, Siton, A., additional, Mashiach, R., additional, Rabinovici, J., additional, Yerushalmi, G. M., additional, Inoue, O., additional, Kuji, N., additional, Fukunaga, T., additional, Ogawa, S., additional, Sugawara, K., additional, Yamada, M., additional, Hamatani, T., additional, Hanabusa, H., additional, Yoshimura, Y., additional, Kato, S., additional, Casarini, L., additional, La Marca, A., additional, Lispi, M., additional, Longobardi, S., additional, Pignatti, E., additional, Simoni, M., additional, Halpern, G., additional, Braga, D. P. A. F., additional, Figueira, R. C. S., additional, Setti, A. S., additional, Iaconelli Jr., A., additional, Borges Jr., E., additional, Vingris, L., additional, Pasqualotto, F. F., additional, Collado-Fernandez, E., additional, Harris, S. E., additional, Cotterill, M., additional, Elder, K., additional, Picton, H. M., additional, Serra, V., additional, Garrido, N., additional, Casanova, C., additional, Lara, C., additional, Remohi, J., additional, Bellver, J., additional, Steiner, H. P., additional, Kim, C. H., additional, You, R. M., additional, Nah, H. Y., additional, Kang, H. J., additional, Kim, S., additional, Chae, H. D., additional, Kang, B. M., additional, Reig Viader, R., additional, Brieno Enriquez, M. A., additional, Toran, N., additional, Cabero, L., additional, Giulotto, E., additional, Garcia Caldes, M., additional, Ruiz-Herrera, A., additional, Brieno-Enriquez, M., additional, Reig-Viader, R., additional, Martinez, F., additional, Garcia-Caldes, M., additional, Velthut, A., additional, Zilmer, M., additional, Zilmer, K., additional, Haller T. Kaart, E., additional, Karro, H., additional, Salumets, A., additional, Bromfield, J. J., additional, Sheldon, I. M., additional, Rezacova, J., additional, Madar, J., additional, Cuchalova, L., additional, Fiserova, A., additional, Shao, R., additional, and Billig, H., additional

Published
2011
Full Text
View/download PDF

4. Posters * Reproductive Endocrinology (i.e. PCOS, Menarche, Menopause etc.)

Author

Fujii, R., primary, Fujita, S., additional, Waseda, T., additional, Oka, Y., additional, Takagi, H., additional, Tomizawa, H., additional, Sasagawa, T., additional, Makinoda, S., additional, Cavagna, M., additional, Braga, D. P. A. F., additional, Figueira, R. C. S., additional, Aoki, T., additional, Maldonado, L. G. L., additional, Iaconelli, A., additional, Borges, E., additional, Prabhakar, s., additional, Dittrich, R., additional, Beckmann, M. W., additional, Hoffmann, I., additional, Mueller, A., additional, Kjotrod, S., additional, Carlsen, S. M., additional, Rasmussen, P. E., additional, Holst-Larsen, T., additional, Mellembakken, J., additional, Thurin-Kjellberg, A., additional, Haapaniemi Kouru, K., additional, Morin Papunen, L., additional, Humaidan, P., additional, Sunde, A., additional, von During, V., additional, Pappalardo, S., additional, Valeri, C., additional, Crescenzi, F., additional, Manna, C., additional, Sallam, H. N., additional, Polec, A., additional, Raki, M., additional, Tanbo, T., additional, Abyholm, T., additional, Fedorcsak, P., additional, Tabanelli, C., additional, Ferraretti, A. P., additional, Feliciani, E., additional, Magli, M. C., additional, Fasolino, C., additional, Gianaroli, L., additional, Wang, T., additional, Feng, C., additional, Song, Y., additional, Dong, M. Y., additional, Sheng, J. Z., additional, Huang, H. F., additional, Sayyah Melli, M., additional, Kazemi-shishvan, M., additional, Snajderova, M., additional, Zemkova, D., additional, Pechova, M., additional, Teslik, L., additional, Lanska, V., additional, Ketel, I., additional, Serne, E., additional, Stehouwer, C., additional, Korsen, T., additional, Hompes, P., additional, Smulders, Y., additional, Voorstemans, L., additional, Homburg, R., additional, Lambalk, C., additional, Bellver, J., additional, Martinez-Conejero, J. A., additional, Pellicer, A., additional, Labarta, E., additional, Alama, P., additional, Melo, M. A. B., additional, Horcajadas, J. A., additional, Agirregoitia, N., additional, Peralta, L., additional, Mendoza, R., additional, Exposito, A., additional, Matorras, R., additional, Agirregoitia, E., additional, Ajina, M., additional, Chaouache, N., additional, Gaddas, M., additional, Souissi, A., additional, Tabka, Z., additional, Saad, A., additional, Zaouali-Ajina, M., additional, Zbidi, A., additional, Eguchi, N., additional, Jinno, M., additional, Watanabe, A., additional, Hirohama, J., additional, Hatakeyama, N., additional, Choi, Y. M., additional, Kim, J. J., additional, Kim, D. H., additional, Yoon, S. H., additional, Ku, S. Y., additional, Kim, S. H., additional, Kim, J. G., additional, Lee, K. S., additional, Moon, S. Y., additional, Xiong, Y., additional, Liang, X., additional, Li, Y., additional, Yang, X., additional, Wei, L., additional, Fujii, R., additional, Utsunomiya, T., additional, Chu, S., additional, Li, P., additional, Akarsu, S., additional, Dirican, E. K., additional, Akin, K. O., additional, Kormaz, C., additional, Goktolga, U., additional, Ceyhan, S. T., additional, Kara, C., additional, Nadamoto, K., additional, Tarui, S., additional, Ida, M., additional, Sugihara, K., additional, Haruki, A., additional, Hukuda, A., additional, Morimoto, Y., additional, Albu, A., additional, Albu, D., additional, Sandu, L., additional, Kong, G., additional, Cheung, L., additional, Lok, I., additional, Pinto, A., additional, Teixeira, L., additional, Figueiredo, H., additional, Pires, I., additional, Silva Carvalho, J. L., additional, Pereira, M. L., additional, Faut, M., additional, de Zuniga, I., additional, Colaci, D., additional, Barrios, E., additional, Oubina, A., additional, Terrado Gil, G., additional, Motta, A., additional, Horton, M., additional, Sobral, F., additional, Gomez Pena, M., additional, Gleicher, N., additional, Barad, D. H., additional, Li, Y. P., additional, Zhao, H. C., additional, Spaczynski, R. Z., additional, Guzik, P., additional, Banaszewska, B., additional, Krauze, T., additional, Wykretowicz, A., additional, Wysocki, H., additional, Pawelczyk, L., additional, Sarikaya, E., additional, Gulerman, C., additional, Cicek, N., additional, Mollamahmutoglu, L., additional, Venetis, C. A., additional, Kolibianakis, E. M., additional, Toulis, K., additional, Goulis, D., additional, Loutradi, K., additional, Chatzimeletiou, K., additional, Papadimas, I., additional, Bontis, I., additional, Tarlatzis, B. C., additional, Schultze-Mosgau, A., additional, Griesinger, G., additional, Schoepper, B., additional, Cordes, T., additional, Diedrich, K., additional, Al-Hasani, S., additional, Gomez, R., additional, Jovanovic, V., additional, Sauer, C. M., additional, Shawber, C. J., additional, Sauer, M. V., additional, Kitajewski, J., additional, Zimmermann, R. C., additional, Bungum, L., additional, Jacobsson, A. K., additional, Rosen, F., additional, Becker, C., additional, Andersen, C. Y., additional, Guner, N., additional, Giwercman, A., additional, Kiapekou, E., additional, Zapanti, E., additional, Boukelatou, D., additional, Mavreli, T., additional, Bletsa, R., additional, Stefanidis, K., additional, Drakakis, P., additional, Mastorakos, G., additional, Loutradis, D., additional, Malhotra, N., additional, Sharma, V., additional, Kumar, S., additional, Roy, K. K., additional, Sharma, J. B., additional, Ferraretti, A., additional, Crippa, A., additional, Stanghellini, I., additional, Robles, F., additional, Serdynska-Szuster, M., additional, Kristensen, S. L., additional, Ernst, E., additional, Toft, G., additional, Olsen, S. F., additional, Bonde, J. P., additional, Vested, A., additional, Ramlau-Hansen, C. H., additional, Wang, F. F., additional, Qu, F., additional, Ding, G. L., additional, Gallot, V., additional, Genro, V., additional, Roux, I., additional, Scheffer, J. B., additional, Frydman, R., additional, Fanchin, R., additional, Kanta Goswami, S., additional, Banerjee, S., additional, Chakravarty, B. N., additional, Kabir, S. N., additional, Seeber, B. E., additional, Morandell, E., additional, Kurzthaler, D., additional, Wildt, L., additional, Dieplinger, H., additional, Tutuncu, L., additional, Bodur, S., additional, Dundar, O., additional, Ron - El, R., additional, Seger, R., additional, Komarovsky, D., additional, Kasterstein, E., additional, Komsky, A., additional, Maslansky, B., additional, Strassburger, D., additional, Ben-Ami, I., additional, Zhao, X. M., additional, Ni, R. M., additional, Lin, L., additional, Dong, M., additional, Tu, C. H., additional, He, Z. H., additional, Yang, D. Z., additional, Karamalegos, C., additional, Polidoropoulos, N., additional, Papanikopoulos, C., additional, Stefanis, P., additional, Argyrou, M., additional, Doriza, S., additional, Sisi, V., additional, Moschopoulou, M., additional, Karagianni, T., additional, Mentorou, C., additional, Economou, K., additional, Davies, S., additional, Mastrominas, M., additional, Gougeon, A., additional, De Los Santos, M. J., additional, Garcia-Laez, V., additional, Esteban, F., additional, Crespo, J., additional, Li, H. W. R., additional, Anderson, R. A., additional, Yeung, W. S. B., additional, Ho, P. C., additional, Ng, E. H. Y., additional, Yang, H. I., additional, Lee, K. E., additional, Seo, S. K., additional, Kim, H. Y., additional, Cho, S. H., additional, Choi, Y. S., additional, Lee, B. S., additional, Park, K. H., additional, Cho, D. J., additional, Hart, R., additional, Doherty, D., additional, Mori, T., additional, Hickey, M., additional, Sloboda, D., additional, Norman, R., additional, Huang, R. C., additional, Beilin, L., additional, Freiesleben, N., additional, Lossl, K., additional, Johannsen, T. H., additional, Loft, A., additional, Bangsboll, S., additional, Hougaard, D., additional, Friis-Hansen, L., additional, Christiansen, M., additional, Nyboe Andersen, A., additional, Thum, M. Y., additional, Abdalla, H., additional, Martinez-Salazar, J., additional, De la Fuente, G., additional, Kohls, G., additional, Garcia Velasco, J. A., additional, Yasmin, E., additional, Kukreja, S., additional, Barth, J., additional, Balen, A. H., additional, Esra, T., additional, Var, T., additional, Citil, A., additional, Dogan, M., additional, Messini, C. I., additional, Dafopoulos, K., additional, Chalvatzas, N., additional, Georgoulias, P., additional, Anifandis, G., additional, Messinis, I. E., additional, Celik, O., additional, Hascalik, S., additional, Celik, N., additional, Sahin, I., additional, Aydin, S., additional, Hanna, C. W., additional, Bretherick, K. L., additional, Liu, C. C., additional, Stephenson, M. D., additional, Robinson, W. P., additional, Louwers, Y. V., additional, Goodarzi, M. O., additional, Taylor, K. D., additional, Jones, M. R., additional, Cui, J., additional, Kwon, S., additional, Chen, Y. D. I., additional, Guo, X., additional, Stolk, L., additional, Uitterlinden, A. G., additional, Laven, J. S. E., additional, Azziz, R., additional, Navaratnarajah, R., additional, Grun, B., additional, Sinclair, J., additional, Dafou, D., additional, Gayther, S., additional, Timms, J. F., additional, Hardiman, P. J., additional, Ye, Y., additional, Wu, R., additional, Ou, J., additional, Kim, S. D., additional, Jee, B. C., additional, Lee, J. Y., additional, Suh, C. S., additional, Jung, J. H., additional, Opmeer, B. C., additional, Broeze, K. A., additional, Coppus, S. F., additional, Collins, J. A., additional, Den Hartog, J. E., additional, Land, J. A., additional, Van der Linden, P. J., additional, Marianowski, P., additional, Ng, E., additional, Van der Steeg, J. W., additional, Steures, P., additional, Strandell, A., additional, Mol, B. W., additional, Tarlatzi, T. B., additional, Kyrou, D., additional, Mertzanidou, A., additional, Fatemi, H. M., additional, Devroey, P., additional, Batenburg, T. E., additional, Konig, T. E., additional, Overbeek, A., additional, Schats, R., additional, Lambalk, C. B., additional, Carone, D., additional, Vizziello, G., additional, Vitti, A., additional, Chiappetta, R., additional, Topcu, H. O., additional, Yuksel, B., additional, Islimye, M., additional, Karakaya, J., additional, ozat, M., additional, Batioglu, S., additional, Kuchenbecker, W. K., additional, Groen, H., additional, Bolster, J. H., additional, van Asselt, S., additional, Wolffenbuettel, B. H., additional, Hoek, A., additional, Wu, Y., additional, Pan, H., additional, Chen, X., additional, Huang, H., additional, Zavos, A., additional, Verikouki, C., additional, Van Os, L., additional, Vink-Ranti, C. Q. J., additional, Rijnders, P. M., additional, Tucker, K. E., additional, Jansen, C. A. M., additional, Lucco, F., additional, Pozzobon, C., additional, Lara, E., additional, Galliano, D., additional, Ballesteros, A., additional, Ghoshdastidar, B., additional, Maity, S. P., additional, Ghoshdastidar, S., additional, Luna, M., additional, Vela, G., additional, Sandler, B., additional, Barritt, J., additional, Flisser, E. D., additional, Copperman, A. B., additional, Nogueira, D., additional, Prat, L., additional, Degoy, J., additional, Bonald, F., additional, Montagut, J., additional, Maity, S., additional, Chen, S., additional, Luo, C., additional, Zhen, H., additional, Shi, X., additional, Wu, F., additional, Ni, Y., additional, Merdassi, G., additional, Chaker, A., additional, Kacem, K., additional, Benmeftah, M., additional, Fourati, S., additional, Wahabi, D., additional, Zhioua, F., additional, Zhioua, A., additional, Saini, P., additional, Saini, A., additional, Sugiyama, R., additional, Nakagawa, K., additional, Nishi, Y., additional, Jyuen, H., additional, Kuribayashi, Y., additional, Inoue, M., additional, Jancar, N., additional, Vrtacnik Bokal, E., additional, Virant-Klun, I., additional, Lee, J. H., additional, Kim, S. G., additional, Cha, E. M., additional, Park, I. H., additional, Lee, K. H., additional, Dahdouh, E. M., additional, Desrosiers, P., additional, St-Michel, P., additional, Villeneuve, M., additional, Fontaine, J. Y., additional, Granger, L., additional, Ramon, O., additional, Burgos, J., additional, Abanto, E., additional, Gonzalez, M., additional, Mugica, J., additional, Corcostegui, B., additional, Tal, J., additional, Ziskind, G., additional, Ohel, G., additional, Paltieli, Y., additional, Paz, G., additional, Lewit, N., additional, Sendel, H., additional, Khouri, S., additional, Calderon, I., additional, van Gelder, P., additional, Al-Inany, H. G., additional, Antaki, R., additional, Dean, N., additional, Lapensee, L., additional, Racicot, M., additional, Menard, S., additional, Kadoch, I., additional, Meylaerts, L. J., additional, Dreesen, L., additional, Vandersteen, M., additional, Neumann, C., additional, Zollner, U., additional, Kato, K., additional, Segawa, T., additional, Kawachiya, S., additional, Okuno, T., additional, Kobayashi, T., additional, Takehara, Y., additional, Kato, O., additional, Jayaprakasan, K., additional, Nardo, L., additional, Hopkisson, J., additional, Campbell, B., additional, and Raine-Fenning, N., additional

Published
2010
Full Text
View/download PDF

5. Session 05: Endometriosis: Impact, Diagnosis and Surgery

Author

Nnoaham, K. E., primary, Sivananthan, S., additional, Hummelshoj, L., additional, Jenkinson, C., additional, Webster, P., additional, Kennedy, S. H., additional, Zondervan, K. T., additional, Vodolazkaia, A., additional, Fassbender, A., additional, Kyama, C. M., additional, Bokor, A., additional, Clerinx, P., additional, Gevaert, O., additional, Schols, D., additional, Huskens, D., additional, Meuleman, C., additional, Peeraer, K., additional, Tomassetti, C., additional, De Moor, B., additional, D'Hooghe, T. M., additional, Opoien, H. K., additional, Fedorcsak, P., additional, Abyholm, T., additional, Tanbo, T. G., additional, Kavallaris, A., additional, Hornemann, A., additional, Bohlmann, M., additional, Griesinger, G., additional, Chalvatzas, N., additional, Diedrich, K., additional, Benaglia, L., additional, Pasin, R., additional, Somigliana, E., additional, Vercellini, P., additional, Ragni, G., additional, Fedele, L., additional, Bergqvist, A., additional, Lundholm, C., additional, Malki, N., additional, Swahn, M. L., additional, Sparen, P., additional, and Melin, A., additional

Published
2010
Full Text
View/download PDF

10. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility.

Author

Omland, A. K., Fedorcsák, P., Storeng, R., Dale, P. O., Åbyholm, T., Tanbo, T., Fedorcsák, P, and Abyholm, T

Subjects
INFERTILITY treatment, COMPARATIVE studies, ENDOMETRIOSIS, ENDOMETRIUM, ESTRADIOL, FALLOPIAN tube diseases, FERTILIZATION in vitro, FOLLICLE-stimulating hormone, INFERTILITY, LONGITUDINAL method, LUTEAL phase, LUTEINIZING hormone, RESEARCH methodology, MEDICAL cooperation, MENSTRUAL cycle, OVARIES, PROGESTERONE, RESEARCH, EVALUATION research, TREATMENT effectiveness, DISEASE complications
Abstract

Background: To elucidate possible differences between unexplained and minimal peritoneal endometriosis-associated infertility, we studied their outcome in natural cycle IVF (NIVF).Methods: A prospective cohort study was carried out on unexplained (33 couples), minimal peritoneal endometriosis-associated (30 couples) and tubal factor (24 couples) infertility in 223 NIVF cycles, using human chorionic gonadotrophin (HCG) for ovulation induction.Results: During the first NIVF attempt, follicular and luteal phase oestradiol, FSH, LH and progesterone concentrations, as well as endometrial thickness and follicular diameter were similar among the three groups. Periovulatory follicular growth monitored from day of HCG administration to oocyte aspiration was significantly lowered in unexplained infertility compared with minimal endometriosis-associated and tubal factor infertility. The fertilization rate, clinical pregnancy rate per initiated cycle, per successful oocyte retrieval and per embryo transfer, in minimal endometriosis (80.0, 10.4, 16.0 and 23.5% respectively) were similar to that in tubal factor infertility patients (68.6, 5.8, 11.4 and 16.0%) but significantly higher (P < 0.05) than that of the unexplained infertility group (62.2, 2.6, 5.4 and 8.7%).Conclusions: The significant reduction in follicular periovulatory growth, fertilization and pregnancy rates in unexplained infertility compared with minimal peritoneal endometriosis patients may be explained by sub-optimal follicular development with possibly reduced oocyte quality, intrinsic embryo quality factors or by impaired implantation. From a clinical point of view, NIVF is less suited to unexplained infertility treatment, but might represent an interesting treatment option for minimal peritoneal endometriosis-associated infertility. [ABSTRACT FROM AUTHOR]

Published
2001
Full Text
View/download PDF

11. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.

Author

Fedorcsák, Péter, Dale, Per Olav, Storeng, Ritsa, Tanbo, Tom, Åbyholm, Thomas, Fedorcsák, P, Dale, P O, Storeng, R, Tanbo, T, and Abyholm, T

Abstract

The impact of insulin resistance on the outcome of IVF or intracytoplasmic sperm injection (ICSI) in women with polycystic ovarian syndrome (PCOS) was examined. Insulin sensitivity was measured by the continuous infusion of glucose with model assessment (CIGMA) test. Insulin-resistant (n = 26) and non-insulin-resistant women (n = 30) with PCOS underwent a total of 100 cycles of long-term down-regulation with buserelin acetate, stimulation with human recombinant FSH, and IVF or ICSI. Blood samples were taken throughout ovarian stimulation for hormone assays. Insulin-resistant and non-insulin-resistant women had similar concentrations of FSH, LH, testosterone and androstenedione throughout stimulation, but insulin-resistant women had hyperinsulinaemia and lower sex hormone binding globulin concentrations. Insulin-resistant women also had lower oestradiol concentrations during stimulation and required higher FSH doses, but these differences disappeared after controlling for the higher body weight in the group of insulin-resistant women. Groups had similar number of oocytes collected, similar implantation and pregnancy rates, and the incidence of ovarian hyperstimulation syndrome was also similar. Obesity, independent of hyperinsulinaemia, was related to a lower oocyte count and increased FSH requirement. It is concluded that in PCOS women receiving long-term down-regulation and stimulation with recombinant FSH, insulin resistance is neither related to hormone levels nor to IVF outcome. Obesity, independent of insulin resistance, is associated with relative gonadotrophin resistance. [ABSTRACT FROM AUTHOR]

Published
2001
Full Text
View/download PDF

12. Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells.

Author

Holst, N, Jacobsen, M B, Haug, E, Tanbo, T, and Abyholm, T

Abstract

To study the effect of somatostatin on ovarian function, we investigated the action of physiological concentrations of somatostatin (5.0 x 10(-12)-1.0 x 10(-10) M) on the basal and luteinizing hormone (LH)-stimulated progesterone release from cultured human granulosa-luteal cells obtained from in-vitro fertilization patients. Somatostatin exerted a significant and inhibitory effect on basal progesterone release from the granulosa-luteal cells, whereas it was unable to inhibit LH-stimulated progesterone release. Instead, a significant increase in progesterone release was observed after concomitant incubation with LH and somatostatin compared with the untreated controls. We suggest that somatostatin may serve as a regulator of ovarian functions under physiological conditions. [ABSTRACT FROM AUTHOR]

Published
1995

13. Somatostatin in human follicular fluid.

Author

Holst, N., Haug, E., Tanbo, T., Åbyholm, T., Jacobsen, M.B., and Abyholm, T

Abstract

To demonstrate the presence of somatostatin in human pre-ovulatory follicular fluid, and to assess the role of this peptide in follicular maturation, a total of 66 follicular fluid samples were obtained from 26 patients at the time of oocyte recovery for in-vitro fertilization. Follicular fluid concentrations of somatostatin, oestradiol, progesterone and androstenedione were measured by immunoassays. Somatostatin concentrations in concomitantly obtained plasma samples were also analysed. Follicular fluid somatostatin concentrations ranged from undetectable (<1.5 pmol/1) to 109.4 pmol/1. The mean ±SE somatostatin concentrations in follicular fluid (12.8± 1.8 pmol/1) were significantly (P< 0.0001) increased compared to corresponding plasma concentrations of somatostatin (6.5 ± 0.2 pmol/1). A significant and positive correlation existed between follicular fluid and plasma somatostatin concentrations ( = 0.27; < 0.03). No differences in either follicular fluid or plasma somatostatin concentrations were found between different stimulation protocols or diagnostic groups. Neither did follicular fluid somatostatin concentration vary with follicular size. Similarly, no differences in somatostatin concentrations were found between follicular fluids associated with fertilized (13.2 ± 2.1 pmol/1) or non-fertilized oocytes (10.5± 1.6 pmol/1). Follicular fluid concentrations of somatostatin correlated positively with those of progesterone ( % 0.30; = < 0.04), but not with those of oestradiol or androstenedione or with the androstenedione/oestradiol ratio. The relationship between follicular fluid somatostatin and progesterone concentrations suggests that follicular fluid somatostatin may have a physiological role in follicular maturation and the luteinization process. [ABSTRACT FROM PUBLISHER]

Published
1994

14. In-vitro fertilization in infertile women with the polycystic ovarian syndrome.

Author

Dale, Per Olav, Tanbo, Tom, Åbyholm, Thomas, Dale, P O, Tanbo, T, and Abyholm, T

Subjects
INFERTILITY treatment, LUTEINIZING hormone releasing hormone, FERTILIZATION in vitro, INFERTILITY, INDUCED ovulation, POLYCYSTIC ovary syndrome, DISEASE complications, THERAPEUTICS
Abstract

Forty-four infertile patients with the polycystic ovarian syndrome (PCOS) resistant to other treatment modalities were treated in 58 cycles of IVF after accomplishment of pituitary gonadotroph suppression with a GnRH-agonist. Four cycles were cancelled before oocyte retrieval while embryo transfer was deferred for 10 cycles due to imminent ovarian hyperstimulation syndrome (OHSS). Follicle aspiration yielded 18.8±9 oocytes per cycle. The cleavage rate was 68%. There was no cleavage in five cycles. The pregnancy rate was 33.3% per embryo transfer. In 32 cycles 9.0±5 suitable supernumerary embryos were cryopreserved. Transfer of cryopreserved embryos gave three additional pregnancies. The accumulated pregnancy rate per patient was 36%. In clomiphene citrate resistant patients, transfer of cryopreserved embryos was accomplished after secretory transformation of the endometrium by oestradiollprogester one substitution. Although seven pregnancies ended in a miscarriage, the ‘take-home’ baby rate was 20%. OHSS ensued in 28(46.7%) cycles. In PCOS, in-vitro fertilization following pituitary gonadotroph suppression seems a treatment alternative with pregnancy rates comparable to normo-ovulatory women with tubal factor infertility. However, the incidence of OHSS is high and constitutes the major problem of cycle control. [ABSTRACT FROM PUBLISHER]

Published
1991

15. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders.

Author

Tanbo, T, Abyholm, T, Bjøro, T, and Dale, P O

Subjects
GONADOTROPIN, INFERTILITY treatment, OVARIAN surgery, LUTEINIZING hormone releasing hormone, CLOMIPHENE, ESTRADIOL, FERTILIZATION in vitro, FOLLICLE-stimulating hormone, INFERTILITY, LUTEINIZING hormone, OVARIES, THERAPEUTICS
Abstract

Forty-three patients who responded poorly to previous stimulation with clomiphene citrate (CC)/human menopausal gonadotrophin (HMG) for IVF were followed during 70 further cycles. Eighteen patients had a normal FSH response to CC in the previous cycle, while 25 had an abnormal FSH response. Three stimulation protocols were used: buserelin/HMG, CC/HMG and HMG only. No difference between the two groups was observed in the dose of HMG used for any stimulation protocol. More cycles were cancelled due to a poor response in the abnormal response group compared to the normal response group. In the completed cycles, the maximum oestradiol level and number of oocytes retrieved were lower in the abnormal response group compared to the normal response group. The total pregnancy rate per patient, including spontaneous conceptions during the study period, was lower in the abnormal response group compared to the normal response group, 4 versus 33%. We conclude that poor responders with an abnormal FSH response to CC have a latent ovarian failure with a low chance of success in further IVF attempts. [ABSTRACT FROM AUTHOR]

Published
1990

16. Assisted fertilization in infertile women with patent fallopian tubes. A comparison of in-vitro fertilization, gamete intra-fallopian transfer and tubal embryo stage transfer.

Author

Tanbo, T, Dale, P O, and Abyholm, T

Subjects
INFERTILITY treatment, COMPARATIVE studies, CONCEPTION, EMBRYO transfer, FALLOPIAN tubes, FERTILIZATION in vitro, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, INDUCED ovulation, RESEARCH, EVALUATION research, FETAL development, GAMETE intrafallopian transfer
Abstract

A comparison of the relative efficacy of in-vitro fertilization with uterine embryo transfer (IVF), tubal embryo stage transfer (TEST) and gamete intra-Fallopian transfer (GIFT) was performed in infertile patients with patent Fallopian tubes. A total of 150 couples with unexplained infertility, peritoneal endometriosis or reduced semen quality were included in the study. The three groups were comparable with regard to age distribution, indications, semen parameters, stimulation regimens, response to stimulation and numbers of oocytes retrieved. In the IVF and TEST groups there was no cleavage in 24% and a cleavage rate of only 47.6%. The highest cleavage rate was obtained in the endometriosis patients. The pregnancy rate was highest in the two groups in which in-vitro fertilization was performed, IVF = 45.7%, TEST = 37.9%, GIFT = 26.2%. To obtain one live intrauterine fetus, more oocytes had to be transferred in the GIFT group compared to the number of embryos in the IVF group, 14.4 versus 6.2, P less than 0.05. Due to a high success rate of IVF but at the same time a high frequency of no cleavage in cases of unexplained infertility or male subfertility, we recommend IVF as the primary procedure in infertile couples with patent Fallopian tubes. [ABSTRACT FROM AUTHOR]

Published
1990

17. Ionized calcium in human male and female reproductive fluids: relationships to sperm motility.

Author

Magnus, o., Åbyholm, T., Kofstad, J., Purvis, K., and Abyholm, T

Abstract

The levels of ionized calcium in seminal plasma were approximately 20% of the serum levels. In contrast, cervical mucus contained a level of ionized calcium similar to both serum and follicular fluid. Titration of seminal plasma and serum with increasing concentrations of calcium chloride indicated a 10-fold higher calcium-binding capacity for seminal plasma. In a random group of men under semen investigation, concentrations of ionized calcium and citrate in semen were inversely correlated (r = 0.732; P less than 0.001), an observation which was confirmed by studies of split ejaculates. These findings supported the contention that citrate is the major regulator of the levels of ionized calcium in seminal plasma and primarily responsible for maintaining the calcium gradient between the seminal plasma and cervical mucus. No significant relationship could be demonstrated between the levels of ionized calcium in the ejaculates and any of the motility characteristics of the spermatozoa in the same sample. Furthermore, the addition of increasing quantities of calcium chloride (0.16-20.00 mM) to washed spermatozoa had no major effects on their progressive motility. These data suggest that human spermatozoa are effective in maintaining an appropriate level of internal ionized calcium, necessary for normal motility, despite fluctuations in external calcium. [ABSTRACT FROM AUTHOR]

Published
1990

18. Epithelial cells from human fallopian tube in culture.

Author

Henriksen, T., Tanbo, T., Åbyholm, Th., Oppedal, B.R., Claussen, O.P., Hovig, T., and Abyholm, T

Abstract

The epithelial cells lining the inner surface of the Fallopian tube influence the reproductive process by both their ciliary and secretory activities. The aim of the present work was to establish a method to culture these cells as a model for more specific studies of their properties. Minor slices of the mucosal ridges were cut and minced extensively using a fine scissor. The resulting pieces were washed once, resuspended in RPMI 1640 with 20% fetal calf serum and seeded in plastic dishes. After 2 days, the medium was replaced with RPMI 1640 containing human albumin, insulin and transferrin. Seven to 10 days later, the cell number had increased 5−8 times in 70% of the cultures. The identity of the cells was assessed after 1−3 weeks in culture. Of the cells, 98% stained positive for the antibody to epithelial cell-specific protein cytokeratin. Electron microscopic studies of the cultures showed epithelial characteristics including cilia, microvUli and intercellular junctions in the form of desmosomes. The cells could be kept in culture for 6−8 weeks. In conclusion, a method to culture epithelial cells from the human Fallopian tube is described. The cells have been identified and they can be kept in culture for 6−8 weeks in quantities sufficient for experimental use. [ABSTRACT FROM PUBLISHER]

Published
1990

19. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization.

Author

Tanbo, T, Dale, P O, Abyholm, T, and Stokke, K T

Subjects
ESTRADIOL, FERTILIZATION in vitro, FOLLICLE-stimulating hormone, GONADOTROPIN, LUTEINIZING hormone, MENSTRUAL cycle, PROGNOSIS, PROLACTIN, CLOMIPHENE, PHARMACODYNAMICS
Abstract

Follicle-stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and prolactin levels were studied in a sequential clomiphene citrate/human menopausal gonadotrophin (CC/HMG) regimen for in-vitro fertilization. At completion of CC administration, the median FSH level in 44 cancelled cycles was elevated compared to a control group of 65 completed cycles, 29 IU/l versus 15 IU/l, P less than 0.01. Also the median FSH/LH ratio was higher in the cancelled cycles than in the control group, 1.08 versus 0.71, P less than 0.05. Conversely, the median oestradiol level was lower in the cancelled cycles than in the completed cycles, 0.27 nmol/l versus 0.59 nmol/l, P less than 0.01. No difference was seen in the median LH and prolactin levels. An FSH value above the 95% confidence limit was found in 24 of the cancelled cycles, but in only two of the completed cycles. Based on this study, an elevated FSH value following CC administration predicts a poor response to further stimulation with an accuracy of 92.3% and should result in cancellation of the cycle. [ABSTRACT FROM AUTHOR]

Published
1989

20. Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization.

Author

Bjercke, S, Tanbo, T, Dale, P O, Mørkrid, L, and Abyholm, T

Abstract

There is increased risk of early pregnancy loss after assisted reproduction. In this study the use of serum human chorionic gonadotrophin (HCG) concentrations on day 12 after in-vitro fertilization (IVF) and embryo transfer was evaluated to predict pregnancy outcome. A total of 417 IVF pregnancies were included. Early pregnancy loss was defined as biochemical pregnancies, ectopic pregnancies and first trimester abortions. Vital pregnancies were defined as delivered singletons, multiple pregnancies and second trimester abortions. On the post embryo transfer day 12, the mean HCG concentration of the vital pregnancy group was significantly higher than in early pregnancy loss outcomes (P < 0.00001). Receiver operating characteristic (ROC) curve analysis was performed to evaluate the cut-off value of HCG giving maximal sensitivity and specificity in order to discriminate early pregnancy losses from vital pregnancies. A patient with a HCG value higher than the calculated cut-off value (55 IU/l) had a 90% chance of having a vital pregnancy after IVF and embryo transfer. It can be concluded that a discriminatory HCG value on day 12 after IVF and embryo transfer cycles may be useful in predicting pregnancy outcome and may guide clinicians in identifying those pregnancies at risk for adverse outcomes and instituting more intensive surveillance in this population.

Published
1999
Full Text
View/download PDF

21. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.

Author

Dale, P O, Tanbo, T, Haug, E, and Abyholm, T

Abstract

We studied 23 women with polycystic ovarian syndrome (PCOS), resistant to clomiphene citrate, who had a previous history of multifollicular ovarian development on gonadotrophin stimulation. Each woman had one cycle of gonadotrophin-stimulating hormone agonist/human menopausal gonadotrophin (GnRHa/HMG) stimulation and then one cycle of low-dose follicle stimulating hormone (FSH) stimulation. All GnRHa/HMG cycles were multifollicular. On the low-dose FSH protocol, 10 cycles were unifollicular, while two to three follicles were observed in nine cycles, and four cycles were multifollicular. The ovarian hyperstimulation syndrome ensued in one of the FSH cycles versus 13 of the GnRHa/HMG cycles. Despite decreasing luteinizing hormone (LH) levels and increasing FSH levels, androgen levels increased during stimulation on both protocols. There was one pregnancy in the GnRHa/HMG cycles versus six pregnancies following the FSH cycles. In conclusion, low-dose FSH administration seems a safe stimulation regimen with a satisfactory conception rate even in PCOS women with a previous record of multifollicular ovarian development.

Published
1992
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results